EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria

Yaoguang Li, Sizhen Liu iD, Peng Han, Jun Lei, Huifen Wang, Weiwei Zhu, Zihui Dong, Yize Zhang, Zhi Jiang, Beiwen Zheng iD, Guanhua Rao iD, Zujiang Yu iD und 1 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02592-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Yaoguang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gene Hospital of Henan Province, Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Machine Learning, Anti-Bacterial Agents, High-Throughput Nucleotide Sequencing, Bacteria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is an escalating global health crisis, underscoring the urgent need for timely and targeted therapies to ensure effective clinical treatment. We developed a machine learning model based on metagenomic next-generation sequencing (mNGS) for rapid antimicrobial susceptibility prediction (mNGS-based AST), which was tailored to five ESKAPEE bacteria: Acinetobacter baumannii , Klebsiella pneumoniae , Escherichia coli , Pseudomonas aeruginosa, and Staphylococcus aureus . However, the clinical utility remained unvalidated. Assuming that mNGS-based AST results were obtained during clinical management, we assessed its clinical utility using data from a previous observational cohort study of clinical mNGS applications. We collected the data from 114 patients infected with five ESKAPEE bacteria from 07/2021 to 03/2023 and incorporated the sequencing data into the model. We evaluated the performance and hypothetical impact of the method by comparing its results and therapy recommendations with those based on traditional culture-based AST. The primary outcome was the performance of mNGS-based AST ( n = 113 strains). mNGS-based AST displayed an overall accuracy of 93.84% and shorter turnaround time (1.12 ± 0.33 days vs 2.81 ± 0.57 days for culture-based AST, t = −27.31, P < 0.05). The secondary outcomes included the proportion of patients who could benefit from mNGS-based AST. It could allow earlier and suitable antibacterial adjustments in 32.05% of culture-positive patients (25/78) and offer actionable antimicrobial susceptibility results in 16.67% of culture-negative cases (6/36). mNGS-based AST offers a promising approach for individualized antibacterial therapy. IMPORTANCE Metagenomic next-generation sequencing (mNGS)-based antimicrobial susceptibility prediction (AST) is a novel method for predicting the antimicrobial susceptibility of ESKAPEE bacteria using a machine learning approach and short-read sequencing data. Assuming that mNGS-based AST results were obtained during clinical management, it could significantly reduce turnaround time while maintaining a high level of accuracy, allowing for earlier therapeutic adjustments for patients. Furthermore, mNGS-based AST can be integrated with clinical mNGS to maximize the utility of short-read data without substantial cost increases. This study demonstrates the potential of mNGS-based AST for precise, individualized antibacterial selection and highlights its broader applicability in enhancing clinical antimicrobial use for various infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAnti-Bacterial AgentsHigh-Throughput Nucleotide SequencingBacteriaBacterial InfectionsHumansMicrobial Sensitivity TestsKlebsiella pneumoniaeAcinetobacter baumanniiMaleMiddle AgedFemaleStaphylococcus aureusEscherichia coliPseudomonas aeruginosaAgedMetagenomicsAdult

Stichwörter der Autor:innen

ESKAPEEantimicrobial susceptibility testinggenotypic antimicrobial susceptibility testingmachine learningmetagenomic next-generation sequencing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Gene Hospital of Henan Province, Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Infectious Disease, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Genskey Medical Technology Co., Ltd., Beijing, China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of M…

ORCID-Profile: Sizhen Liu, Beiwen Zheng, Guanhua Rao, Zujiang Yu, Ang Li

Zitieren

APA

Li, Y., Liu, S., Han, P., Lei, J., Wang, H., Zhu, W., Dong, Z., Zhang, Y., Jiang, Z., Zheng, B., Rao, G., Yu, Z., & Li, A. (2025). Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02592-24

Vancouver

Li Y, Liu S, Han P, Lei J, Wang H, Zhu W, et al. Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02592-24

BibTeX
@article{Li2025,
  author = {Li, Yaoguang and Liu, Sizhen and Han, Peng and Lei, Jun and Wang, Huifen and Zhu, Weiwei and Dong, Zihui and Zhang, Yize and Jiang, Zhi and Zheng, Beiwen and Rao, Guanhua and Yu, Zujiang and Li, Ang},
  title = {Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02592-24}
}
Kostenlos starten →